L-Theanine Pediatric Dosing
Based on the single available pediatric trial, L-theanine 400 mg daily (200 mg twice daily) is the evidence-based dose for children ages 8-12 years, administered as chewable tablets at breakfast and after school. 1
Evidence-Based Dosing Parameters
Established Pediatric Dose
- Total daily dose: 400 mg/day divided into two doses (200 mg twice daily) 1
- Administration timing: Morning (breakfast) and afternoon (after school) 1
- Formulation: Chewable tablets (100 mg per tablet, two tablets per dose) 1
- Age range studied: 8-12 years in boys with ADHD 1
- Duration of safe use: 6 weeks demonstrated in clinical trial 1
Weight-Based Dosing
No weight-based dosing guidelines exist in the pediatric literature. The single pediatric trial used a fixed dose of 400 mg/day regardless of weight in school-age children. 1
Maximum Daily Limit
- Pediatric maximum: 400 mg/day is the only dose studied in children 1
- Adult safety data: Up to 900 mg/day has been studied in adults, with no observable adverse effect level (NOAEL) above 2000 mg/kg/day in toxicology studies 2
- Conservative approach: Do not exceed 400 mg/day in pediatric patients given limited safety data beyond this dose
Clinical Context and Safety
Demonstrated Efficacy in Children
The 400 mg/day dose in boys with ADHD showed: 1
- Significantly improved sleep percentage and sleep efficiency
- Reduced nighttime activity (less time awake after sleep onset)
- Well-tolerated with no significant adverse events
- Safe in both stimulant-treated and non-stimulant-treated ADHD patients
Critical Safety Considerations
- Limited pediatric data: Only one randomized controlled trial exists in children 1
- Age restrictions: No data for children under 8 years of age
- Duration limits: Safety beyond 6 weeks is not established in pediatrics 1
- Gender data: The pediatric trial only included male subjects 1
Practical Prescribing Algorithm
For children 8-12 years:
- Start with 200 mg twice daily (at breakfast and after school) 1
- Continue for up to 6 weeks with monitoring 1
- Assess response using objective sleep measures or behavioral outcomes 1
For children under 8 years or over 12 years:
- No established pediatric dosing exists
- Consider risk-benefit ratio carefully given absence of safety data
- If used off-label, do not exceed 400 mg/day and monitor closely
For adolescents approaching adult size:
- May consider adult dosing of 200-450 mg/day based on adult literature 3
- Adult studies support 200-400 mg/day as safe and effective 4, 5
Important Caveats
Lack of Comprehensive Pediatric Guidelines
- No formal pediatric dosing guidelines exist from major medical societies
- The FDA drug label provided discusses liothyronine (thyroid hormone), not L-theanine, indicating no FDA-approved pediatric L-theanine formulation 6
- All pediatric use is based on a single research trial, not guideline-level evidence 1
Monitoring Recommendations
- Parents may not accurately perceive sleep quality changes, so objective measures are preferred when possible 1
- Watch for any behavioral changes or adverse effects
- Discontinue if no benefit after 6 weeks 1
Drug Interactions
While not specifically studied in the pediatric trial, L-theanine was safely used in children taking stimulant medications for ADHD. 1